Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

Human Molecular Genetics
James R MaxwellAnthony G Wilson

Abstract

Anti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumatoid arthritis (RA). These therapies are, however, expensive and 30% of patients fail to respond. In a large cohort of Caucasian RA patients treated with anti-TNF medications (total n = 1050, etanercept n = 455, infliximab n = 450), we investigated whether genotypes of eight single nucleotide polymorphisms in the region containing the TNF gene were associated with response to anti-TNF therapy. Linear regression analyses adjusted for baseline 28 joint disease activity score (DAS28), baseline health assessment questionnaire score, gender and concurrent disease modifying anti-rheumatic drug treatment were used to assess association of these polymorphisms with treatment response, defined by change in DAS28 after 6 months. Analyses were performed in the entire cohort, and also stratified by anti-TNF agent. Association between DAS28 response and TNF-308 (rs1800629) genotype (P = 0.001) was detected across the whole cohort. After stratification by anti-TNF agent, the rare TNF-308AA genotype was associated with a significantly poorer response compared with TNF-308GG in etanercept (P = 0.001, n = 7) but not infliximab (P = 0.8, n = 17) trea...Continue Reading

References

Oct 1, 1995·Human Genetics·G M Galbraith, J P Pandey
Nov 1, 1995·The Journal of Experimental Medicine·M CabreraJ M Blackwell
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·A G WilsonG W Duff
Jan 18, 1997·Lancet·R G WestendorpJ P Vandenbrouke
Nov 30, 2000·The New England Journal of Medicine·P E LipskyUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Bernie ScallonCarrie Wagner
Oct 9, 2003·Annals of the Rheumatic Diseases·A SilmanI Griffiths
Feb 20, 2004·Genes and Immunity·J-P BayleyC L Verweij
Apr 13, 2004·Arthritis and Rheumatism·Alfonso MartinezBenjamin Fernandez-Gutierrez
Apr 27, 2005·Seminars in Arthritis and Rheumatism·Ivan Nestorov
Oct 29, 2005·Nature·UNKNOWN International HapMap Consortium
May 25, 2006·Bioinformatics·Xavier SoléVíctor Moreno

❮ Previous
Next ❯

Citations

Dec 12, 2012·Zeitschrift für Rheumatologie·M Frank, T Mittendorf
Jun 27, 2012·Current Opinion in Rheumatology·Mara L Becker
Nov 8, 2012·International Journal of Rheumatology·A ScardapaneF Chiarelli
Apr 1, 2009·Therapeutic Advances in Musculoskeletal Disease·Paula I BurgosS Louis Bridges
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Darren D O'Rielly, Proton Rahman
Jun 6, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Laura J Gibbons, Kimme L Hyrich
Nov 3, 2011·Pharmacogenomics·Rita PrajapatiAnne Barton
Feb 27, 2013·Pharmacogenomics·Maša Umićević Mirkov, Marieke J H Coenen
Feb 19, 2014·Nature Reviews. Rheumatology·Darren PlantAnne Barton
Sep 18, 2014·Database : the Journal of Biological Databases and Curation·Ruijie ZhangYongshuai Jiang
Nov 22, 2014·Dermatologic Clinics·Amy C Foulkes, Richard B Warren
Dec 3, 2014·Expert Review of Molecular Diagnostics·David S GibsonAnthony J Bjourson
Nov 27, 2015·Expert Opinion on Drug Metabolism & Toxicology·Maciej TarnowskiAndrzej Pawlik
Oct 11, 2014·Expert Opinion on Drug Metabolism & Toxicology·Giuseppe MurdacaFrancesco Puppo
Dec 4, 2013·Expert Opinion on Biological Therapy·Xi XieFen Li
Apr 7, 2012·Joint, Bone, Spine : Revue Du Rhumatisme·María José Morales-LaraPablo Conesa-Zamora
Jul 6, 2010·Human Immunology·Kashi N PrasadVimal K Paliwal
May 19, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Hubert Marotte, Pierre Miossec
Nov 25, 2011·The Journal of Investigative Dermatology·Trilokraj TejasviRajan P Nair
Nov 5, 2011·The British Journal of Dermatology·H L HébertR B Warren
Nov 3, 2010·British Journal of Pharmacology·Devesh Mewar, Anthony G Wilson
Dec 25, 2010·International Journal of Dermatology·Stéphane DalleNeil H Shear
Aug 24, 2012·International Journal of Dermatology·Lyubomir DourmishevVanio Mitev
Jul 24, 2014·Dermatologic Therapy·Jacek KarczewskiZygmunt Adamski
Nov 18, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Maha-Abdulla HamadienOmar Al-Obeed
Mar 3, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·C De SimoneA Sgambato
Oct 19, 2011·Cytokine·Isobel R GowersAnthony G Wilson
Jun 17, 2015·Biomarkers in Medicine·James OliverAnne Barton
Nov 16, 2014·BMC Musculoskeletal Disorders·Suotang Kou, Yaochi Wu
Dec 17, 2014·Experimental Gerontology·Javier Rodríguez-CarrioAna Suárez
Jun 25, 2017·The British Journal of Dermatology·L J van VugtE M G J de Jong
May 21, 2014·The American Journal of Gastroenterology·Mahmoud H MosliBrian G Feagan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.